Title: An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562
101772-29-6
102520-97-8
1363382-11-9
167938-56-9
183059-24-7
204191-40-2
1256268-95-7 | 3-(Methylamino)pyridazine-4-carbonitrile | AA000NVL | MFCD19227735
1256355-27-7 | Pyridine-4-boronic acid hydrate | AA000O0P | MFCD08061353
1256360-06-1 | 1-(Ethoxycarbonyl)pyrrole-3-boronic acid, pinacol ester | AA000O5A | MFCD16036144
1256819-37-0 | 2-Bromo-6-chloro-3-methoxypyridine | AA000OC8 | MFCD18255399
1632992-45-0 | 2-(6-Methyl-4,8-dioxo-1,3,6,2-dioxazaborocan-2-yl)benzaldehyde | AA000OKG | MFCD11215212
119-84-6 | Dihydrocoumarin | AA000OWT | MFCD00006881
1196-69-6 | 5-Formylindole | AA000P6I | MFCD02093664
1197-60-0 | 2-Furanmethanaminium, N,N,N,5-tetramethyl-, iodide (1:1) | AA000PEW | MFCD00153835
119812-29-2 | 3-[(Dimethylamino)methyl]-1,2,3,9-tetrahydro-9-methyl-4h-carbazol-4-one HCl | AA000PMO | MFCD08668589
1199773-46-0 | N-(Furan-2-ylmethyl) 4-(4-bromopyrazol-1-yl)benzenesulfonamide | AA000PVI | MFCD13195743